An Open-Label, Randomized, Parallel, Phase II Trial to Evaluate the Efficacy and Safety of a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel as First-Line Treatment for Ovarian Cancer: A Korean Gynecologic Oncology Group Study (KGOG-3021)

PURPOSE: Genexol-PM is a biodegradable cremophor EL–free polymeric micelle formulation of paclitaxel. Here,we compared efficacy and safety of Genexol-PM plus carboplatin versus Genexol plus carboplatin for ovarian cancer treatment. MATERIALS AND METHODS: In this multicenter, randomized, phase II stu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Res Treat
Glavni autori: Lee, Shin-Wha, Kim, Yong-Man, Cho, Chi Heum, Kim, Young Tae, Kim, Seok Mo, Hur, Soo Young, Kim, Jae-Hoon, Kim, Byoung-Gie, Kim, Seung-Cheol, Ryu, Hee-Sug, Kang, Soon Beom
Format: Artigo
Jezik:Inglês
Izdano: Korean Cancer Association 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5784626/
https://ncbi.nlm.nih.gov/pubmed/28324920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.376
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items